These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 16210859

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL.
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [Abstract] [Full Text] [Related]

  • 3. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
    Reinartz SM, Overbeek SE, Kleinjan A, van Drunen CM, Braunstahl GJ, Hoogsteden HC, Fokkens WJ.
    Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis.
    Wilson AM, Duong M, Crawford L, Denburg J.
    Clin Exp Allergy; 2005 Jan; 35(1):39-44. PubMed ID: 15649264
    [Abstract] [Full Text] [Related]

  • 5. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis.
    Linden M, Svensson C, Andersson M, Greiff L, Andersson E, Denburg JA, Persson CG.
    Allergy; 1999 Mar; 54(3):212-9. PubMed ID: 10321556
    [Abstract] [Full Text] [Related]

  • 6. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U.
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE, Lumry WR, Anolik R.
    J Investig Allergol Clin Immunol; 2009 Jan; 19(2):117-24. PubMed ID: 19476015
    [Abstract] [Full Text] [Related]

  • 8. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P, Dreyfus I, Dhivert-Donnadieu H, Mesbah K.
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [Abstract] [Full Text] [Related]

  • 9. Desloratadine partially inhibits the augmented bacterial responses in the sinuses of allergic and infected mice.
    Kirtsreesakul V, Blair C, Yu X, Thompson K, Naclerio RM.
    Clin Exp Allergy; 2004 Oct; 34(10):1649-54. PubMed ID: 15479283
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH.
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [Abstract] [Full Text] [Related]

  • 11. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.
    Dizdar EA, Sekerel BE, Keskin O, Kalayci O, Adalioglu G, Dogan C, Tuncer A.
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):843-9. PubMed ID: 17346807
    [Abstract] [Full Text] [Related]

  • 12. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA.
    Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
    [Abstract] [Full Text] [Related]

  • 13. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C.
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE, White MV, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
    Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Jensen CB, Fokkens WJ, Ring J, Keith P, Gopalan G, Lorber R, Zuberbier T, ACCEPT-2 Study Group.
    Int Arch Allergy Immunol; 2010 Aug; 153(4):395-402. PubMed ID: 20559006
    [Abstract] [Full Text] [Related]

  • 19. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A, Neukirch C, Dreyfus I, Devillier P.
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.